Enrollment ongoing in phase I/II study of EXG-34217 in patients with bone marrow failure April 15, 2021
FDA clears initiation of first-in-human study of CRISPR_SCD-001 for sickle cell disease March 31, 2021
Cellphire initiates phase II study of Thrombosomes for bleeding in patients with thrombocytopenia March 22, 2021
RSS